Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Alx Oncology Holdings (ALXO) Return on Capital Employed (2020 - 2023)

Alx Oncology Holdings' Return on Capital Employed history spans 4 years, with the latest figure at 0.78% for Q3 2023.

  • For Q3 2023, Return on Capital Employed fell 59.0% year-over-year to 0.78%; the TTM value through Sep 2023 reached 0.78%, down 59.0%, while the annual FY2022 figure was 0.4%, 36.0% down from the prior year.
  • Return on Capital Employed for Q3 2023 was 0.78% at Alx Oncology Holdings, down from 0.56% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.03% in Q4 2020 and bottomed at 0.78% in Q3 2023.
  • The 4-year median for Return on Capital Employed is 0.14% (2022), against an average of 0.24%.
  • The largest annual shift saw Return on Capital Employed rose 7bps in 2021 before it plummeted -59bps in 2023.
  • A 4-year view of Return on Capital Employed shows it stood at 0.03% in 2020, then plummeted by -68bps to 0.05% in 2021, then crashed by -860bps to 0.45% in 2022, then crashed by -74bps to 0.78% in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Return on Capital Employed are 0.78% (Q3 2023), 0.56% (Q2 2023), and 0.5% (Q1 2023).